Wockhardt is proud to announce the successful completion of its pivotal Phase 3 pneumonia study involving the macrolide antibiotic Nafithromycin WCK 4873. This significant achievement marks a crucial step forward in the development of effective pneumonia treatments. Comparative Evaluation and Impressive Results: The study compared Nafithromycin, also known as WCK 4873, against the last-line respiratory […]
China is grappling with a staggering surge in respiratory illnesses, prompting the National Health Commission to call for an urgent increase in the number of fever clinics. National Health Commission spokesperson Mi Feng, addressing a press conference, revealed that the surge is attributed to the simultaneous circulation of multiple pathogens, with influenza being the most […]
In an alarming development, China reports a significant surge in respiratory illnesses among children in the north, causing international concern. The World Health Organization (WHO), after pressing China for more details, revealed that no unusual or new pathogens were found. Despite the absence of new pathogens, the sheer volume of cases has sparked global attention, […]
China is facing a new health emergency as a mysterious pneumonia outbreak, eerily reminiscent of the early COVID-19 crisis, sweeps through schools. Hospitals in Beijing and Liaoning, already burdened by the pandemic’s aftermath, are now struggling with a fresh influx of sick children. This alarming development has led to concerns about imminent school closures, as […]
GlaxoSmithKline (GSK) has agreed to acquire Affinivax, a Boston-based clinical-stage vaccine developer, in a deal worth up to $3.3 billion. The consideration includes an upfront payment of $2.1 billion and payments of up to $1.2 billion based on potential development milestones. Affinivax is engaged in developing vaccines by using its Multiple Antigen Presenting System (MAPS) […]
RedHill Biopharma has forged partnerships with a couple of US-based manufacturers for large-scale manufacturing of opaganib, its Covid-19 drug candidate. The Israeli biopharma company said that the collaborations further progress its ongoing preparations to underpin potential emergency use applications for opaganib for the treatment of severe Covid-19 pneumonia, which are anticipated as early as Q1 […]
Humanigen said that lenzilumab has delivered a clinically meaningful impact on the recovery of patients hospitalized with Covid-19, as per the interim data of a phase 3 trial. According to the US biopharma company, the interim analysis for sizing and powering, an estimated 37% more recoveries were seen in the lenzilumab arm of the randomized, […]
Veklury EU approval : Gilead Sciences said that Veklury (remdesivir) has been given conditional marketing authorization from the European Commission as a treatment for SARS-CoV-2 infection, the virus behind COVID-19. According to the US pharma company, the conditional marketing authorization for Veklury was given in the interest of public health because of the coronavirus pandemic […]
Remdesivir clinical trial results : Gilead Sciences said that the phase 3 SIMPLE trial, which has been evaluating the Covid-19 drug candidate remdesivir for the treatment of hospitalized patients with moderate pneumonia associated with novel coronavirus, has yielded promising results. According to the US biopharma company, the Covid-19 drug candidate delivered significantly greater clinical improvement for […]
Zebra Medical Vision (Zebra-Med), an Israel-based deep-learning medical imaging analytics company, said that its software will be deployed by India’s Apollo Hospitals Group to help its doctors in efficient and accurate diagnoses of COVID-19, by leveraging the former’s0 AI1 platform. The duo entered into a collaboration in March 2019 for deploying Zebra Medical Vision’s artificial […]